These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7499305)

  • 21. Changes in adenosine transport associated with melaminophenyl arsenical (Mel CY) resistance in Trypanosoma evansi: down-regulation and affinity changes of the P2 transporter.
    Suswam EA; Ross CA; Martin RJ
    Parasitology; 2003 Dec; 127(Pt 6):543-9. PubMed ID: 14700190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.
    Fairlamb AH; Smith K; Hunter KJ
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):223-31. PubMed ID: 1501642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthesis and uptake of thiamine (vitamin B1) in bloodstream form Trypanosoma brucei brucei and interference of the vitamin with melarsen oxide activity.
    Stoffel SA; Rodenko B; Schweingruber AM; Mäser P; de Koning HP; Schweingruber ME
    Int J Parasitol; 2006 Feb; 36(2):229-36. PubMed ID: 16375907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Transporters Rather than Drug Targets Are the Principal Determinants of the Different Innate Sensitivities of
    Ungogo MA; Campagnaro GD; Alghamdi AH; Natto MJ; de Koning HP
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
    Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
    Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of the nitroimidazole drug megazol by African trypanosomes.
    Barrett MP; Fairlamb AH; Rousseau B; Chauvière G; Perié J
    Biochem Pharmacol; 2000 Mar; 59(6):615-20. PubMed ID: 10677577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei.
    Munday JC; Settimo L; de Koning HP
    Front Pharmacol; 2015; 6():32. PubMed ID: 25814953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future.
    Bray PG; Barrett MP; Ward SA; de Koning HP
    Trends Parasitol; 2003 May; 19(5):232-9. PubMed ID: 12763430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.
    Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP
    Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes.
    Taladriz A; Healy A; Flores Pérez EJ; Herrero García V; Ríos Martínez C; Alkhaldi AA; Eze AA; Kaiser M; de Koning HP; Chana A; Dardonville C
    J Med Chem; 2012 Mar; 55(6):2606-22. PubMed ID: 22390399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Goldberg B; Rattendi D; Lloyd D; Sufrin JR; Bacchi CJ
    Biochem Pharmacol; 2001 Feb; 61(4):449-57. PubMed ID: 11226379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel nucleobase/pentamidine transporters from Trypanosoma brucei.
    Ortiz D; Sanchez MA; Quecke P; Landfear SM
    Mol Biochem Parasitol; 2009 Feb; 163(2):67-76. PubMed ID: 18992774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.
    Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP
    Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of trypanocides by functional expression of an adenosine transporter from Trypanosoma brucei in yeast.
    Mäser P; Vogel D; Schmid C; Räz B; Kaminsky R
    J Mol Med (Berl); 2001 Apr; 79(2-3):121-7. PubMed ID: 11357935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei.
    Van Schaftingen E; Opperdoes FR; Hers HG
    Eur J Biochem; 1987 Aug; 166(3):653-61. PubMed ID: 3038548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity.
    Hulpia F; Campagnaro GD; Scortichini M; Van Hecke K; Maes L; de Koning HP; Caljon G; Van Calenbergh S
    Eur J Med Chem; 2019 Feb; 164():689-705. PubMed ID: 30677668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive computational models of substrate binding by a nucleoside transporter.
    Collar CJ; Al-Salabi MI; Stewart ML; Barrett MP; Wilson WD; de Koning HP
    J Biol Chem; 2009 Dec; 284(49):34028-35. PubMed ID: 19808668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.